NEU 6.41% $15.27 neuren pharmaceuticals limited

Agree Tangentland. My DCF model suggests potential $20-$50...

  1. 406 Posts.
    lightbulb Created with Sketch. 1236
    Agree Tangentland. My DCF model suggests potential $20-$50 billion valuation in 5+ years if potential realized in many of the indications Neuren has discussed. Downside case of $2-$5 billion (assuming Trof approval and limited NNZ-2591 success). Feels like nice odds to me. Here's hoping the market starts thinking like this too soon.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.